不切断Roux-en-Y重建对比经典Roux-en-Y重建在胃癌远端胃切除术中的短期结局:一项前瞻性随机对照试验
该随机对照试验纳入I期胃癌行腹腔镜远端胃切除术患者,比较不切断Roux-en-Y(uncut R-Y)与经典R-Y重建的手术安全性、营养状态和术后生活质量(QOL)。结果显示两组手术时间、出血量、恢复时间、并发症发生率和总生存相似,但uncut R-Y组在术后第9个月QOL显著降低,可能与肠袢再通(占34.2%)有关;排除再通后经典R-Y组QOL仍较高,尽管uncut R-Y组血红蛋白和总蛋白水平更好。结论提示uncut R-Y并未显示显著优于经典R-Y。
要点
- 不切断Roux-en-Y与经典Roux-en-Y在手术安全性及总生存方面无显著差异。
- 不切断Roux-en-Y组术后9个月生活质量显著降低,可能与肠袢再通(34.2%)相关。
- 排除再通后经典R-Y组生活质量仍较高,不切断R-Y未显示优越性。
核心结论
- 不切断Roux-en-Y重建相比经典Roux-en-Y重建未显示显著获益,挑战了其优越性。
研究设计与样本
- 前瞻性随机对照试验,纳入I期胃癌行腹腔镜远端胃切除术患者,随机接受不切断或经典Roux-en-Y重建。
主要发现
- 两组手术时间、出血量、恢复时间、并发症发生率和总生存相似。
- 不切断Roux-en-Y组术后9个月生活质量显著低于经典R-Y组,肠袢再通占该组34.2%。
- 排除再通后,经典R-Y组生活质量仍高于不切断R-Y组,但不切断R-Y组血红蛋白和总蛋白水平更好。
- 术前前白蛋白水平和空腹血糖受损与术后再通显著相关。
临床怎么用
- 对于I期胃癌行腹腔镜远端胃切除术,不切断Roux-en-Y重建未显示优于经典R-Y,选择术式时应权衡生活质量与再通风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Roux-en-Y (R-Y) anastomoses have been widely used in distal gastrectomy, while the incidence of Roux stasis syndrome remains common. Uncut R-Y anastomosis maintains the neuromuscular continuity, thus avoiding the ectopic pacemaker of the Roux limb and reducing the occurrence of Roux stasis. However, retrospective studies of Uncut R-Y anastomosis remain scarce and randomized controlled trials have not been reported. METHODS: We conducted a randomized controlled trial to compare the surgical safety, nutritional status, and postoperative quality of life (QOL) between uncut and classic Roux-en-Y (R-Y) reconstruction patients. Patients with Stage I gastric cancer were randomly enrolled and underwent laparoscopic distal gastrectomy followed by uncut or classic R-Y reconstruction. Body mass index and blood test were used to evaluate the nutritional status. QOL was evaluated using European Organization for Research and Treatment of Cancer QOL Questionnaire (STO22) and laboratory examinations at postoperative month (POM) 3, 6, 9, and 12. Computed tomography scanning was used to evaluate the skeletal muscle index (SMI) at POM 6 and 12. Endoscopy was performed at POM 12. RESULTS: Operation time, blood loss, time to recovery, complication morbidities, and overall survival were similar between the two groups. Compared with the classic R-Y group, the uncut R-Y group displayed a significantly decreased QOL at POM 9, possibly due to loop recanalization, determined to be occupied 34.2% of the uncut R-Y group. Post-exclusion of recanalization, the QOL was still higher in the classic R-Y group than in the uncut R-Y group, despite their hemoglobin and total protein levels being better than those in the classic R-Y group. Preoperative pre-albumin level and impaired fasting glycemia significantly correlated with the postoperative recanalization. CONCLUSION: We found no significant benefit of uncut over classic R-Y reconstruction which challenges the superiority of the uncut R-Y reconstruction. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT02644148.
引用
- Xu H, Yang L, Zhang DC, et al. To cut or not to cut? A prospective randomized controlled trial on short-term outcomes of the uncut Roux-en-Y reconstruction for gastric cancer. Surg Endosc. 2023. PMID: 37160808. doi:10.1007/s00464-023-10067-0
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。